Trinity Biotech Stock Options
| TRIB Stock | USD 0.74 0.01 1.37% |
Trinity Biotech's latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 4.99. The Trinity Biotech option chain provides detailed quote and price information for the current Trinity Biotech plc option contracts. It shows all of Trinity Biotech's listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on Trinity Biotech
Analyzing Trinity Biotech's in-the-money options over time can help investors to take a profitable long position in Trinity Biotech regardless of its overall volatility. This is especially true when Trinity Biotech's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Trinity Biotech's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Trinity Biotech's stock while costing only a fraction of its price.
Trinity Biotech's stock options are financial instruments that give investors the right to buy or sell shares of Trinity Biotech plc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Trinity stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Trinity Biotech's stock price goes up or down, the stock options follow.
At present, Trinity Biotech's Common Stock Shares Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 142.5 M, whereas Total Stockholder Equity is projected to grow to (33.4 M). Trinity Current Options Market Mood
Trinity Biotech's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Trinity Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Trinity Biotech's options investors are not very successful. Trinity Biotech's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Trinity contract
Base on the Rule 16, the options market is currently suggesting that Trinity Biotech plc will have an average daily up or down price movement of about 0.31% per day over the life of the 2025-09-19 option contract. With Trinity Biotech trading at USD 0.74, that is roughly USD 0.002308. If you think that the market is fully incorporating Trinity Biotech's daily price movement you should consider buying Trinity Biotech plc options at the current volatility level of 4.99%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Trinity Biotech options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Trinity calls. Remember, the seller must deliver Trinity Biotech plc stock to the call owner when a call is exercised.
Trinity Biotech Option Chain
When Trinity Biotech's strike price is surpassing the current stock price, the option contract against Trinity Biotech plc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Trinity Biotech's option chain is a display of a range of information that helps investors for ways to trade options on Trinity. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Trinity. It also shows strike prices and maturity days for a Trinity Biotech against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | TRIB250919C00007500 | 0 | 7.5 | 0.0 - 0.75 | 0.75 | |
Call | TRIB250919C00005000 | 0 | 5.0 | 0.0 - 0.75 | 0.75 | |
Call | TRIB250919C00002500 | 0 | 2.5 | 0.0 - 0.75 | 0.75 | |
Put | TRIB250919P00007500 | 0 | 7.5 | 6.6 - 6.9 | 6.6 | In |
Put | TRIB250919P00005000 | 0 | 5.0 | 4.0 - 4.5 | 4.0 | In |
Put | TRIB250919P00002500 | 0 | 2.5 | 0.0 - 1.9 | 1.9 | In |
Trinity Total Stockholder Equity
Total Stockholder Equity |
|
Trinity Biotech Corporate Management
| Simon Dunne | Chief Officer | Profile | |
| Fernando Devia | Ex Sales | Profile | |
| Eibhlin Kelly | Chief Officer | Profile | |
| Susan OConnor | Interim Officer | Profile | |
| Aris Kekedjian | CEO Chairman | Profile | |
| Louise Tallon | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Trinity Biotech plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (1.80) | Revenue Per Share | Quarterly Revenue Growth 0.181 | Return On Assets |
The market value of Trinity Biotech plc is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Biotech's value that differs from its market value or its book value, called intrinsic value, which is Trinity Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Biotech's market value can be influenced by many factors that don't directly affect Trinity Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.